Your browser doesn't support javascript.
loading
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
Penson, Peter E; Bruckert, Eric; Marais, David; Reiner, Zeljko; Pirro, Matteo; Sahebkar, Amirhossein; Bajraktari, Gani; Mirrakhimov, Erkin; Rizzo, Manfredi; Mikhailidis, Dimitri P; Sachinidis, Alexandros; Gaita, Dan; Latkovskis, Gustavs; Mazidi, Mohsen; Toth, Peter P; Pella, Daniel; Alnouri, Fahad; Postadzhiyan, Arman; Yeh, Hung-I; Mancini, G B John; von Haehling, Stephan; Banach, Maciej.
Afiliación
  • Penson PE; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
  • Bruckert E; Liverpool Centre for Cardiovascular Science, Liverpool, UK.
  • Marais D; Pitié-Salpetrière Hospital and Sorbonne University, Cardio metabolic Institute, Paris, France.
  • Reiner Z; Chemical Pathology Division of the Department of Pathology, University of Cape Town Health Science Faculty, Cape Town, South Africa.
  • Pirro M; Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia.
  • Sahebkar A; Department of Medicine, University of Perugia, Perugia, Italy.
  • Bajraktari G; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mirrakhimov E; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rizzo M; Clinic of Cardiology, University Clinical Centre of Kosova, Medical Faculty, University of Prishtina, Prishtina, Kosovo.
  • Mikhailidis DP; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Sachinidis A; Department of Internal Disease, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan.
  • Gaita D; Department of Atherosclerosis and Coronary Heart Disease, National Center of Cardiology and Internal Diseases, Bishkek, Kyrgyzstan.
  • Latkovskis G; Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Mazidi M; Division of Endocrinology, Diabetes and Metabolism, School of Medicine, University of South Carolina, Columbia, SC, USA.
  • Toth PP; Department of Clinical Biochemistry, University College London Medical School, University College London (UCL), London, UK.
  • Pella D; Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Alnouri F; 2nd Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Postadzhiyan A; Universitatea de Medicina si Farmacie Victor Babes, Timisoara, Romania.
  • Yeh HI; Clinica de Cardiologie, Institutul de Boli Cardiovasculare Timisoara, Timisoara, Romania.
  • Mancini GBJ; Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • von Haehling S; University of Latvia, Riga, Latvia.
  • Banach M; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.
J Cachexia Sarcopenia Muscle ; 13(3): 1596-1622, 2022 06.
Article en En | MEDLINE | ID: mdl-35969116
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Enfermedades Musculares Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cachexia Sarcopenia Muscle Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Enfermedades Musculares Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Cachexia Sarcopenia Muscle Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania